SCHEMBL8514568

SCHEMBL8514568

Cc1cc(C(N)CO)ccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV3 Q8NET8 1/20 0.38
DPP4 P27487 3/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
TSHR P16473 1/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
MMP13 P45452 1/20 0.34
AKT1 P31749 1/20 0.34
GBA1 P04062 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRB3 P13945 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
PDE2A O00408 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8514566 1.00 TRPV3 (0.38) TRPV3DPP4HTR2AHTR2CHTR2B
SCHEMBL5407290 0.85 AKR1C3 (0.41) AKR1C3AKR1C2PDE2AALDH1A1
SCHEMBL24262071 0.85 AKR1C3 (0.41) AKR1C3AKR1C2PDE2AALDH1A1
SCHEMBL23560788 0.83 SLC6A4 (0.44) DPP4HTR2AHTR2CHTR2BAKR1C3
SCHEMBL12261550 0.83 SLC6A4 (0.44) DPP4HTR2AHTR2CHTR2BAKR1C3
SCHEMBL4072121 0.82 CES2 (0.42) DPP4PDE2A
SCHEMBL3636225 0.82 ALDH1A1 (0.38) PTGS1SCN10AALDH1A1
SCHEMBL8511287 0.82 CES2 (0.42) DPP4PDE2A
Hydrochloric Acid SCHEMBL23527526 0.81 SLC6A4 (0.43) DPP4HTR2AHTR2CHTR2BTSHR
Hydrochloric Acid SCHEMBL21248352 0.81 SLC6A4 (0.43) DPP4HTR2AHTR2CHTR2BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643313-B9 QUINAZOLINE CARBOXAMIDE AZETIDINES MERCK PATENT GMBH (DE) 2017-02-22 EP disclosed
EP-2643313-B1 QUINAZOLINE CARBOXAMIDE AZETIDINES MERCK PATENT GMBH (DE) 2016-06-29 EP disclosed
US-8946247-B2 Quinazoline carboxamide azetidines MERCK PATENT GMBH (DE) 2015-02-03 US disclosed
EP-2643313-A1 QUINAZOLINE CARBOXAMIDE AZETIDINES Merck Patent GmbH (DE) 2013-10-02 EP disclosed
US-20130252942-A1 QUINAZOLINE CARBOXAMIDE AZETIDINES MERCK PATENT GMBH (DE) 2013-09-26 US disclosed
WO-2012069146-A1 QUINAZOLINE CARBOXAMIDE AZETIDINES MERCK PATENT GMBH (DE) 2012-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130252942-A1 QUINAZOLINE CARBOXAMIDE AZETIDINES AZI2, NQO2, ABL1 TRPV3 4298/4885DPP4 1055/4885HTR2A 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.